Rhumbline Advisers Sensei Biotherapeutics, Inc. Transaction History

Rhumbline Advisers

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$1.49 - $2.3 $24,091 - $37,188	-16,169 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$2.22 - $6.07 $6,049 - $16,540	-2,725 Reduced 14.42%	16,169 $37,000
Q4 2021 Feb 10, 2022	BUY	$4.85 - $10.48 $11,227 - $24,261	2,315 Added 13.96%	18,894 $110,000
Q3 2021 Nov 12, 2021	BUY	$6.89 - $11.99 $114,229 - $198,782	16,579 New	16,579 $174,000

2.23M

Ticker SNSE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,720,300
Market Cap $16M
Description
Sensei Biotherapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of immunotherapies with an initial focus on treatments for cancer. It develops proprietary ImmunoPhage platform, an immunotherapy approach that is designed to utilize bacteriophage to induce a focused and coordinated innate and adaptive immune res...

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

Stay updated on Rhumbline Advisers with notifications on news.